Novel surrogate markers for acute brain damage: Cerebrospinal fluid levels corrrelate with severity of ischemic neurodegeneration in the rat

Journal of Cerebral Blood Flow and Metabolism

Volumn 25, Issue 11, 2005, Pages 1433-1444

  Siman, Robert ^a,b   Zhang, Chen ^a   Roberts, Victoria L ^a   Pitts Kiefer, Alex ^a   Neumar, Robert W ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

14 3 3; Acute neurodegeneration; Calpain; Surrogate marker; Tau

Indexed keywords

CALPAIN; CASPASE; CYSTEINE PROTEINASE; FODRIN; PROTEIN; PROTEIN 14 3 3BETA; PROTEIN 14 3 3ZETA; SILVER; TAU PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CAUDATE NUCLEUS; CEREBROSPINAL FLUID; CORRELATION ANALYSIS; DISEASE MARKER; DISEASE SEVERITY; ENZYME ACTIVATION; FOREBRAIN; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INFERIOR COLLICULUS; MALE; NERVE DEGENERATION; NONHUMAN; PARIETAL LOBE; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; RAT STRAIN; SILVER STAINING; THALAMUS;

ACUTE DISEASE; ANIMALS; BIOLOGICAL MARKERS; BRAIN; BRAIN ISCHEMIA; MALE; NERVE DEGENERATION; NEURONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RATS; RATS, LONG-EVANS;

EID: 27544501339     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jcbfm.9600138     Document Type: Article

References (46)

1. Anderson RE, Hansson LO, Nilsson O, Dijlai-Merzoug R, Settergren G (2001) High serum S100β levels for trauma patients without head injuries. Neurosurgery 48:1255-8
2. Basile AM, Fusi C, Conti AA, Paniccia R, Trefoloni G, Pracucci G, Di Carlo A, Noferi D, Carbonetto F, Pretelli P, Calamai G, Vaccari M, Abbate R, Inzitari D (2001) S-100 protein and neuron-specific enolase as markers of subclinical cerebral damage after cardiac surgery: preliminary observation of a 6-month follow-up study. Eur Neurol 45:151-9
3. Baxter HC, Liu WG, Forster JL, Aitken A, Fraser JR (2002) Immunolocalisation of 14-3-3 isoforms in normal and scrapie-infected murine brain. Neuroscience 109:5-14
4. Berg D, Holzmann C, Riess O (2003) 14-3-3 proteins in the nervous system. Nat Rev Neurosci 4:752-62
5. Blomqvist P, Wieloch T (1985) Ischemic brain damage in rats following cardiac arrest using a long-term recovery model. J Cereb Blood Flow Metab 5:420-31
6. Bottiger BW, Mobes S, Glatzer R, Bauer H, Gries A, Bartsch P, Motsch J, Martin E (2001) Astroglial protein S100β is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest in humans. Circulation 103:2694-8
7. Crain BJ, Westerkam WD, Harrison AH, Nadler JV (1988) Selective neuronal death after transient forebrain ischemia in the Mongolian gerbil: a silver impregnation study. Neuroscience 27:387-402
8. Ginsburg MD, Busto R (1998) Small-animal models of global and focal cerebral ischemia. In: Cerebrovascular disease (Ginsberg MD, Bogousslavsky J, eds), Cambridge, MA: Blackwell, 14-35
9. Gionet TX, Warner DS, Verhaegen M, Thomas JD, Todd MM (1992) Effects of intra-ischemic blood pressure on outcome from 2-vessel occlusion forebrain ischemia in the rat. Brain Res 586:188-94
10. Graham SH, Chen J (2001) Programmed cell death in cerebral ischemia. J Cereb Blood Flow Metab 21:99-109
11. Hasselblatt M, Mooren FC, von Ahsen N, Keyvani K, Fromme A, Schwarze-Eicker K, Senner V, Paulus W (2004) Serum S100β increases in marathon runners reflect extracranial release rather than glial damage. Neurology 62:1634-6
12. Hatakeyama T, Matsumoto M, Brengman JM, Yanagihara T (1988) Immunohistochemical investigation of ischemic and postischemic damage after bilateral carotid occlusion in gerbils. Stroke 19:1526-34
13. Hausler R, Levine RA (2000) Auditory dysfunction in stroke. Acta Otolaryngol 120:689-703
14. Iizuka H, Sakatani K, Young W (1989) Corticofugal axonal degeneration in rats after middle cerebral artery occlusion. Stroke 20:1396-402
15. Lee G, Cowen N, Kirschner M (1988) The primary structure and heterogeneity of tau protein from mouse brain. Science 239:285-8
16. Lipton P (1999) Ischemic cell death in brain neurons. Physiol Rev 79:1431-568
17. Marchi N, Rasmussen P, Kapural M, Fazio V, Kight K, Mayberg MR, Kanner A, Ayumar B, Albensi B, Cavaglia M, Janigro D (2003) Peripheral markers of brain damage and blood-brain barrier dysfunction. Restor Neurol Neurosci 21:109-21
18. Matesic DF, Lin RC (1994) Microtubule-associated protein 2 as an early indicator of ischemia-induced neurodegeneration in the gerbil forebrain. J Neurochem 63:1012-20
19. McAllister TW, Sparling MB, Flashman LA, Saykin AJ (2001) Neuroimaging findings in mild traumatic brain injury. J Clin Exp Neuropsychol 23:775-91
20. McKeating EG, Andrews PJ, Mascia L (1998) Relationship of neuron specific enolase and protein S-100 concentrations in systemic and jugular venous serum to injury severity and outcome after traumatic brain injury. Acta Neurochir Suppl 71:117-9
21. Meynaar IA, Oudemans-van Straaten HM, Wetering J, Verlooy P, Slaats EH, Bosman RJ, Spoel JI, Zandstra DF (2003) Serum neuron-specific enolase predicts outcome in post-anoxic coma: a prospective cohort study. Intensive Care Med 29:189-95
22. Mies G, Kawai K, Saito N, Nagashima G, Nowak TS, Jr, Ruetzler CA, Klatzo I (1993) Cardiac arrest-induced complete cerebral ischemia in the rat: dynamics of postischaemic in vivo calcium uptake and protein synthesis. Neurol Res 15:253-63
23. Miyake T, Hattori T, Fukuda M, Kitamura T (1989) Reactions of S-100-positive glia after injury of mouse cerebral cortex. Brain Res 489:31-40
24. Mussack T, Biberthaler P, Kanz K-G, Wiedermann E, Gippner-Steppert C, Mutschler W, Jochum M (2002) Serum S100β and interleukin-8 as predictive markers for comparative neurologic outcome analysis of patients after cardiac arrest and severe traumatic brain injury. Crit Care Med 30:2669-74
25. Nadler JV, Evenson DA (1983) Use of excitatory amino acids to make axon-sparing lesions of hypothalamus. Methods Enzymol 103:393-400
26. Neumar RW, Meng FH, Mills AM, Xu YA, Zhang C, Welsh FA, Siman R (2001) Calpain activity in the rat brain after transient forebrain ischemia. Exp Neurol 170:27-35
27. Oo TF, Siman R, Burke RE (2002) Distinct nuclear and cytoplasmic localization of caspase cleavage products in two models of induced apoptotic death in dopamine neurons of the substantia nigra. Exp Neurol 75:1-9
28. Persson L, Hardemark HG, Gustafsson J, Rundstrom G, Mendel-Hartvig I, Esscher T, Pahlman S (1987) S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. Stroke 18:911-8
29. Petito CK, Torres-Munoz J, Roberts B, Olarte JP, Nowak TS, Jr, Pulsinelli WA (1997) DNA fragmentation follows delayed neuronal death in CA1 neurons exposed to transient global ischemia in the rat. J Cereb Blood Flow Metab 17:967-76
30. Roberts-Lewis JM, Savage MJ, Marcy VR, Pinsker LR, Siman R. (1994) Immunolocalization of calpain I-mediated spectrin degradation to vulnerable neurons in the ischemic gerbil brain. J Neurosci 14:3934-44
31. Rosen H (1998) Increased serum levels of the S-100 protein are associated with hypoxic brain damage after cardiac arrest. Stroke 29:473-7
32. Saatman KE, Bozyczko-Coyne D, Marcy V, Siman R, McIntosh TK (1996) Prolonged calpain-mediated spectrin breakdown occurs regionally following experimental brain injury in the rat. J Neuropathol Exp Neurol 55:850-60
33. Schmidt-Kastner R, Ophoff BG, Hossmann KA (1990) Pattern of neuronal vulnerability in the cat hippocampus after one hour of global cerebral ischemia. Acta Neuropathol 79:444-55
34. Schmued LC, Albertson C, Slikker W, Jr (1997) Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res 751:37-46
35. Shirasaki Y, Edo N, Sato T (2004) Serum S-100β protein as a biomarker for the assessment of neuroprotectants. Brain Res 1021:159-66
36. Siman R, Bozyczko-Coyne D, Savage MJ, Roberts-Lewis JM (1996) The calcium-activated protease calpain I and ischemia-induced neurodegeneration. Adv Neurol 71:167-74
37. Siman R, Bozyczko-Coyne D, Scott RW (1998) Proteolytic mechanisms for ischemic neurodegeneration. In: Cerebrovascular disease (Ginsberg MD, Bogousslavsky J, eds), Cambridge, MA: Blackwell, 721-34
38. Siman R, McIntosh TK, Soltesz KM, Chen Z, Neumar RW, Roberts VL (2004) Proteins released from degenerating neurons are surrogate markers for acute brain damage. Neurobiol Dis 16:311-20
39. Smith M-L, Bendek G, Dahlgren N, Rosen I, Wieloch T, Siesjo BK (1984) Models for studying long-term recovery following forebrain ischemia in the rat. 2. A two-vessel occlusion model. Acta Neurol Scand 69:385-401
40. Snyder-Ramos SA, Bottiger BW (2003) Molecular markers of brain damage - clinical and ethical implications with particular focus on cardiac arrest. Restor Neurol Neurosci 21:123-39
41. Snyder-Ramos SA, Gruhlke T, Bauer H, Bauer M, Luntz AP, Motsch J, Martin E, Vahl CF, Missler U, Wiesmann M, Bottiger BW (2004) Cerebral and extracerebral release of protein S100β in cardiac surgical patients. Anaesthesia 59:344-9
42. Tiainen M, Roine RO, Pettila V, Takkunen O (2003) Serum neuron-specific enolase and S100β protein in cardiac arrest patients treated with hypothermia. Stroke 34:2881-6
43. Tomimoto H, Yanagihara T (1992) Immunoelectron microscopic study of tubulin and microtubule-associated proteins after transient cerebral ischemia in gerbils. Acta Neuropathol 84:394-9
44. Wunderlich MT, Ebert AD, Kratz T, Goertier M, Jost S, Herrmann M (1999) Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke 30:1190-5
45. Zemlan FP, Jauch EC, Mulchahey JJ, Gabbita SP, Rosenberg WS, Speciale SG, Zuccarello M (2002) C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome. Brain Res 947:131-9
46. Zhang C, Siman R, Xu YA, Mills AM, Frederick JR, Neumar RW (2002) Comparison of calpain and caspase activities in the adult rat brain after transient forebrain ischemia. Neurobiol Dis 10:289-305